ARTICLE | Company News
FDA approves Vivus' avanafil
April 28, 2012 12:08 AM UTC
FDA approved an NDA from Vivus Inc. (NASDAQ:VVUS) for oral Stendra avanafil to treat erectile dysfunction. The fast-acting phosphodiesterase-5 (PDE-5) inhibitor is under review for the indication in E...